Double-blind, Two Period Cross-over, Single Centre Trial in Healthy Subjects Investigating the Influence on the Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Drug After Multiple Dose Administration of Liraglutide
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Liraglutide (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Obesity; Pregnancy; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 09 Jan 2012 Actual initiation date (November 2006) added as reported by ClinicalTrials.gov.
- 09 Jan 2012 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
- 09 Jan 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History